Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

The hydrogel effectively treats hair loss using light to release nitric oxide.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Vitamin D receptor FokI gene variation is not linked to alopecia areata.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Increasing isoleucine intake improved skin and health issues in an infant with maple syrup urine disease.

SRD5A2 enzyme expression varies in benign prostates and can be influenced by inflammation, affecting treatment options.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

PT-20 did not significantly improve gray hair repigmentation.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

The research helps understand how finasteride works and aids drug development.

Dutasteride is effective for treating hair loss.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

People with alopecia areata often have lower vitamin D levels than healthy people.

A gene called HDAC9 might be a new factor in male-pattern baldness.

The new hair product quickly reduces hair shedding in women.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Hairless protein can block vitamin D activation in skin cells.

The gene LRRC15 is more active in balding areas of the scalp compared to non-balding areas.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

A boy's hair loss and bone issues improved with specific vitamin D treatment and calcium.

A genetic mutation in the EDA gene causes hypohidrotic ectodermal dysplasia in cats.